Structural Basis for Aβ1–42 Toxicity Inhibition by Aβ C-Terminal Fragments: Discrete Molecular Dynamics Study
Authors:
- 1 July 2011
- journal article
- research article
- Published by Elsevier in Journal of Molecular Biology
- Vol. 410 (2) , 316-328
Abstract
No abstract availableKeywords
Funding Information
- Larry L. Hillblom Foundation (20052E)
- Purdue University
- National Science Foundation
- National Institutes of Health (AG023661, AG027818)
This publication has 57 references indexed in Scilit:
- Mechanistic Investigation of the Inhibition of Aβ42 Assembly and Neurotoxicity by Aβ42 C-Terminal FragmentsBiochemistry, 2010
- Amyloid-β fibrillogenesis: Structural insight and therapeutic interventionExperimental Neurology, 2010
- Structural conversion of neurotoxic amyloid-β1–42 oligomers to fibrilsNature Structural & Molecular Biology, 2010
- Biophysical Characterization of Aβ42 C-Terminal Fragments: Inhibitors of Aβ42 NeurotoxicityBiochemistry, 2010
- Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's diseaseNature Chemistry, 2009
- The Structure of Aβ42 C-Terminal Fragments Probed by a Combined Experimental and Theoretical StudyJournal of Molecular Biology, 2009
- EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomersNature Structural & Molecular Biology, 2008
- The Alzheimer’s Peptides Aβ40 and 42 Adopt Distinct Conformations in Water: A Combined MD / NMR StudyJournal of Molecular Biology, 2007
- Cyclohexanehexol inhibitors of Aβ aggregation prevent and reverse Alzheimer phenotype in a mouse modelNature Medicine, 2006
- VMD: Visual molecular dynamicsJournal of Molecular Graphics, 1996